The Global Market for Specialty Enzymes is Forecast to Exceed US$5.0 Billion by 2020

Robust Demand from the Pharmaceutical Industry Drives the Global Specialty Enzymes Market, According to a New Report by Global Industry Analysts, Inc.

           

GIA announces the release of a comprehensive global report on Specialty Enzymes. The global market for Specialty Enzymes is forecast to exceed US$5.0 billion by 2020, driven by the robust demand in the pharmaceutical industry and the development of novel high-value enzymes.

The global demand for pharmaceutical enzymes, biocatalysts enzymes, diagnostic enzymes, and enzymes used in biotechnology research, is expected to witness robust growth in the coming years. Future growth for specialty enzymes will benefit from the growing demand for novel high-value enzymes. Product innovation and expanding applications will help support growth in the market. Polymerases and nucleases will witness strong growth, as pharmaceutical companies focus on leveraging biotechnology to develop new drugs. Another key factor supporting the growth of polymerases and nucleases is the rapid development of novel diagnostic tests that target RNA and DNA substrates. Robust growth of the biocatalysts market coupled with the rapid development of sulfatases for enzyme replacement therapies will also offer significant opportunities for market growth.

Therapeutic applications where enzymes are required in very small amounts but in high degree of specificity and purity, will play a key role in spurring consumption patterns worldwide. The growing significance of enzymes in therapies for diseases such as cancer, lysosomal storage disorders, pain and inflammation management, cardiovascular diseases, among others, is a tidal force fuelling market demand. Advancements in technology such as immobilization of enzymes will further widen the use of specialty enzymes in the field of biotechnology, biomedical and pharmaceuticals. Aging population, especially in developed countries, and rising awareness over the nutritional benefits of enzyme supplementation are factors poised to fuel sales of therapeutic and diagnostic enzymes.

As stated by the new market research report on Specialty Enzymes, the United States represents the largest market worldwide, followed by Europe. Technological advances allowing improved utilization of specialty enzymes in major end-use markets, expanding therapeutic applications, and an aging population vulnerable to diseases, are key factors propelling demand for specialty enzymes in the developed markets. Asia Pacific is forecast to emerge as the fastest growing market with a CAGR of 10.5% over the analysis period.

Key companies covered in the report include Advanced Enzyme Technologies Ltd., Advanced Vital Enzymes Ltd., AST Enzymes, Specialty Enzymes & Biotechnologies Co., Affymetrix, Inc., Amano Enzyme Inc., Biocatalysts Ltd., BBI Solutions, Chr. Hansen Holding AS, Codexis Inc., F. Hoffmann-La Roche Ltd., Genzyme Corporation, Life Technologies Corporation, Meteoric Life Sciences, The Soufflet Group, and National Enzyme Company, among others.

The research report titled “Specialty Enzymes: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, growth drivers challenges, mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections in US$ for major geographic markets including the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, South Korea and Rest of Asia-Pacific), Latin America (Brazil, and Rest of Latin America), and Rest of World. Key end-use applications analyzed in the report include Pharmaceuticals & Diagnostics; Research/Biotechnology; and Others. Product categories analyzed in the report include Proteases, Polymerases, Carbohydrases, and Others.